Compare FUL & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FUL | VCYT |
|---|---|---|
| Founded | 1887 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 3.0B |
| IPO Year | N/A | 2013 |
| Metric | FUL | VCYT |
|---|---|---|
| Price | $67.25 | $35.66 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 8 |
| Target Price | ★ $70.20 | $46.00 |
| AVG Volume (30 Days) | 430.5K | ★ 859.3K |
| Earning Date | 03-25-2026 | 02-25-2026 |
| Dividend Yield | ★ 1.39% | N/A |
| EPS Growth | ★ 19.57 | N/A |
| EPS | ★ 2.75 | 0.38 |
| Revenue | ★ $3,473,589,000.00 | $495,141,000.00 |
| Revenue This Year | $2.31 | $16.72 |
| Revenue Next Year | $2.76 | $11.31 |
| P/E Ratio | ★ $24.54 | $94.03 |
| Revenue Growth | N/A | ★ 16.41 |
| 52 Week Low | $47.56 | $22.61 |
| 52 Week High | $68.63 | $50.71 |
| Indicator | FUL | VCYT |
|---|---|---|
| Relative Strength Index (RSI) | 66.37 | 36.58 |
| Support Level | $64.94 | $34.17 |
| Resistance Level | $68.63 | $37.57 |
| Average True Range (ATR) | 1.78 | 1.65 |
| MACD | 0.52 | -0.19 |
| Stochastic Oscillator | 88.57 | 24.96 |
H.B. Fuller Co manufactures and sells adhesives, sealants, and other chemical-based products. The company organizes itself into three segments: Hygiene, Health and Consumable Adhesives, Engineering Adhesives, and Construction Adhesives. It generates the maximum revenue from hygiene, health, and consumable adhesives. This segment produces and supplies a full range of specialty industrial adhesives such as thermoplastic, thermoset, reactive, water-based, and solvent-based products for applications in various markets, including packaging, converting, nonwoven, and hygiene (disposable diapers, feminine care, and medical garments) and health and beauty. The company generates around half of its revenue in the United States.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.